The involvement of small heat shock protein in chemoresistance in ovarian cancer - in vitro study

Ovarian cancer is the most deadly gynecologic malignancy worldwide. Although the primary response to chemotherapy is high, the majority of patients will develop resistance against applied treatment. In this study, we focused on resistance to cisplatin, a first-line drug used for the treatment of ova...

Descripción completa

Detalles Bibliográficos
Autores principales: Wyciszkiewicz, Aleksandra, Lach, Michal S., Wróblewska, Joanna P., Michalak, Marcin, Suchorska, Wiktoria M., Kalinowska, Alicja, Michalak, Slawomir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222634/
https://www.ncbi.nlm.nih.gov/pubmed/34177409
http://dx.doi.org/10.17179/excli2021-3706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222634/
https://www.ncbi.nlm.nih.gov/pubmed/34177409
http://dx.doi.org/10.17179/excli2021-3706

Ejemplares similares